Anti-neurofilament antibodies in blood of patients with neurological diseases
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 72 (1) , 82-85
- https://doi.org/10.1007/bf00687951
Abstract
A method has been developed to determine quantitatively the level of the anti-neurofilament antibodies in the blood of patients affected with different neurological diseases. In 7 out of the 52 patients, taken as controls and in 33 out of the 208 patients affected with neurological diseases, the antibody levels were increased. The increases were greater in 43 patients with Parkinson dementia and amyotrophic lateral sclerosis who originated from Guam. On the other hand, the levels were very low in 10 patients affected with subacute sclerosing panencephalitis and in 11 cases with Chagaz' disease. In 24 cases with dementia of Alzheimer type, the levels were normal.This publication has 7 references indexed in Scilit:
- Circulating Autoantibodies to the 200,000-Dalton Protein of Neurofilaments in the Serum of Healthy IndividualsScience, 1985
- The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases.Proceedings of the National Academy of Sciences, 1985
- Characterization of Antineurofilament Autoantibodies in Creutzfeldt-Jakob DiseaseJournal of Neuropathology and Experimental Neurology, 1984
- Serum antibodies to neurofilament antigens in patients with neurological and other diseases and in healthy controlsJournal of Neuroimmunology, 1983
- Purification of individual components of the neurofilament triplet: filament assembly from the 70000-dalton subunitBiochemistry, 1982
- Intermediate filaments in nervous tissuesThe Journal of cell biology, 1978